Literature DB >> 10460935

Evidence for genetic heterogeneity in benign familial hematuria.

M Piccini1, G Casari, J Zhou, M Bruttini, S L Volti, A Ballabio, A Renieri.   

Abstract

Benign familial hematuria (BFH: MIM141200) is an autosomal-dominant disease accounting for one-fifth of all hematuria of unknown cause in children. Previous observations suggest that BFH may be allelic to recessive Alport syndrome (AS: MIM 203780) with a mutation in the COL4A3/COL4A4 locus. However, it is not clear whether all cases of BFH are due to heterozygous mutation of COL4A3/COL4A4 genes. We report here the exclusion of linkage between BFH and COL4A3/COL4A4 loci at 2q35-37 in a restricted population from Sicily (Italy). Total lod score is -9.6 at theta 0. Furthermore, in some cases exclusion of linkage is evident even considering single families. We conclude that BFH is genetically heterogeneous.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10460935     DOI: 10.1159/000013499

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  4 in total

1.  Glomerular basement membrane and related glomerular disease.

Authors:  Ying Maggie Chen; Jeffrey H Miner
Journal:  Transl Res       Date:  2012-04-10       Impact factor: 7.012

2.  Improving mutation screening in familial hematuric nephropathies through next generation sequencing.

Authors:  Vincent Morinière; Karin Dahan; Pascale Hilbert; Marieline Lison; Said Lebbah; Alexandra Topa; Christine Bole-Feysot; Solenn Pruvost; Patrick Nitschke; Emmanuelle Plaisier; Bertrand Knebelmann; Marie-Alice Macher; Laure-Hélène Noel; Marie-Claire Gubler; Corinne Antignac; Laurence Heidet
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

3.  Persistent familial hematuria in children and the locus for thin basement membrane nephropathy.

Authors:  Kesha Rana; Yan Yan Wang; Harley Powell; Colin Jones; David McCredie; Mark Buzza; Madhara Udawela; Judy Savige
Journal:  Pediatr Nephrol       Date:  2005-10-19       Impact factor: 3.714

Review 4.  Alport syndrome: facts and opinions.

Authors:  Clifford Kashtan
Journal:  F1000Res       Date:  2017-01-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.